Brief: Ligand Pharmaceuticals Is Buying Xoma For Nearly $740 Million - WSJ
April 27 (Reuters) - LIGAND PHARMACEUTICALS IS BUYING XOMA FOR NEARLY $740 MILLION - WSJ LIGAND PHARMACEUTICALS' DEAL FOR XOMA WOULD VALUE XOMA AT $39 A SHARE - WSJ Source text: https://tinyurl.com/2pcc9x4r Further company coverage: LGND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xoma Royalty
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM